RecruitingNot ApplicableNCT05560113

Disrupting Fear-based Memory Consolidation

Forgetting Fear: Establishing a Novel Non-invasive Approach to Disrupt Fear-based Sensory Memory Consolidation in Humans


Sponsor

Emory University

Enrollment

66 participants

Start Date

Nov 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This project represents a unique collaborative opportunity to pursue the essential proof-of-principle demonstration that non-invasive interference of sensory cortical memory consolidation shortly after an emotional experience can attenuate the cued fear response and potentially reduce the risk of developing post-traumatic stress disorder (PTSD). If successful, the study results would anchor a potential advance in the treatment of patients after a traumatic event and seed future animal and clinical studies of emotional sensory cortical memory consolidation to reduce the prevalence and negative sequelae of PTSD.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a brain stimulation technique (called transcranial magnetic stimulation or TMS) used right after a fearful experience can disrupt how that fear memory gets stored in the brain. The goal is to develop better treatments for PTSD by interfering with the fear memory consolidation process. **You may be eligible if:** - You are able to give informed consent - You are willing to participate in the study - You have no history of musculoskeletal or neurological disease - You have been clinically diagnosed with PTSD (for the PTSD group) **You may NOT be eligible if:** - You are outside the specified age range for the study - You show signs of dementia (scoring below 20 on a cognitive screening test) - You have a history of major head trauma, a neurodegenerative disorder, or recent (within 6 months) substance abuse - You are currently taking psychoactive medications - You have symptoms of psychosis or bipolar disorder - You are pregnant - You have contraindications to TMS or MRI Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERContinuous theta burst stimulation (cTBS)

cTBS, a patterned form of TMS, (80% active motor threshold intensity, 3 pulses at 50Hz, 200ms interval, 600 pulses, 40s duration applied over the targeted sensory cortical region using real-time neuronavigation to focally and transiently inhibit neural activity

OTHERSham continuous theta burst stimulation (cTBS)

This will be a sham intervention. An active/sham stimulating coil will be used for double-blinding of stimulation condition. cTBS is safe and has established safety guidelines that will be strictly adhered to during study conduction.


Locations(2)

Emory Rehabilitation Hospital

Atlanta, Georgia, United States

Emory University Hospital

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05560113


Related Trials